Direct-acting antivirals for the treatment of chronic hepatitis C in patients with chronic kidney disease
Algolia Search

Direct-acting antivirals for the treatment of chronic hepatitis C in patients with chronic kidney disease

All-oral, direct-acting antivirals have significantly improved the efficacy and safety of chronic hepatitis C treatment but their effectiveness and safety among patients with chronic kidney disease remains poorly understood.

Open Article!